Abstract
This study was conducted to demonstrate the possible protective and therapeutic effects of naringenin, an estrogenically effective flavonoid, in experimental autoimmune encephalomyelitis (EAE), which is the rodent model of multiple sclerosis. For this purpose, 50 12-week-old C57BL6 male mice were divided into five groups; control, naringenin, EAE, prophylactic naringenin + EAE, and EAE + therapeutic naringenin. The EAE model was induced with myelin oligodendrocyte glycoprotein(35–55), and naringenin (50 mg/kg) was administered by oral gavage. The prophylactic and therapeutic effects of naringenin were examined according to clinical, histopathological, immunohistochemical, electron microscopic, and RT–PCR (aromatase, 3βHSD, estrogen receptors, and progesterone receptor expression) parameters. The acute EAE model was successfully induced, along with its clinical and histopathological findings. RT–PCR showed that expression of aromatase, 3βHSD, estrogen receptor-β, and progesterone receptor gene decreased, while estrogen receptor-α increased after EAE induction. Electron microscopic analysis showed mitochondrial damage and degenerative changes in myelinated axons and neurons in EAE, which could be behind the downregulation in the expressions of neurosteroid enzymes. Aromatase immunopositivity rates also decreased in EAE, while estrogen receptor α and β, and progesterone receptor immunopositivity rates increased. Naringenin improved aromatase immunopositivity rates and gene expression in both prophylactic and therapeutic use. Clinical and histopathological findings revealed that EAE findings were alleviated in both prophylactic and therapeutic groups, along with significantly decreased inflammatory cell infiltrations in the white matter of the spinal cords. In conclusion, naringenin could provide long-term beneficial effects even in prophylactic use due to stimulating aromatase expression, but it could not prevent or eliminate the EAE model’s lesions completely.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Akwa Y, Sananes N, Gouezou M, Robel P, Baulieu EE, Le Goascogne C (1993) Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density. J Cell Biol 121(1):135–143. https://doi.org/10.1083/jcb.121.1.135
Arvanitis DN, Wang H, Bagshaw RD, Callahan JW, Boggs JM (2004) Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes. J Neurosci Res 75(5):603–613. https://doi.org/10.1002/jnr.20017
Bebo BF Jr, Dehghani B, Foster S, Kurniawan A, Lopez FJ, Sherman LS (2009) Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia 57(7):777–790. https://doi.org/10.1002/glia.20805
Benagiano M, Bianchi P, D’Elios MM, Brosens I, Benagiano G (2019) Autoimmune diseases: role of steroid hormones. Best Pract Res Clin Obstet Gynaecol 60:24–34. https://doi.org/10.1016/j.bpobgyn.2019.03.001
Bodhankar S, Wang C, Vandenbark AA, Offner H (2011) Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells. Eur J Immunol 41(4):1165–1175. https://doi.org/10.1002/eji.201040992
Breinholt VM, Svendsen GW, Dragsted LO, Hossaini A (2004) The citrus-derived flavonoid naringenin exerts uterotrophic effects in female mice at human relevant doses. Basic Clin Pharmacol Toxicol 94(1):30–36
Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP (2000) Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141(10):3646–3656. https://doi.org/10.1210/endo.141.10.7693
Buchanan CD, Mahesh VB, Brann DW (2000) Estrogen-astrocyte-luteinizing hormone-releasing hormone signaling: a role for transforming growth factor-beta(1). Biol Reprod 62(6):1710–1721. https://doi.org/10.1095/biolreprod62.6.1710
Bustamante-Barrientos FA, Mendez-Ruette M, Ortloff A, Luz-Crawford P, Rivera FJ, Figueroa CD, Molina L, Batiz LF (2021) The impact of estrogen and estrogen-like molecules in neurogenesis and neurodegeneration: beneficial or harmful? Front Cell Neurosci 15:636176. https://doi.org/10.3389/fncel.2021.636176
Cavia-Saiz M, Busto MD, Pilar-Izquierdo MC, Ortega N, Perez-Mateos M, Muniz P (2010) Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study. J Sci Food Agric 90(7):1238–1244. https://doi.org/10.1002/jsfa.3959
Chao CL, Weng CS, Chang NC, Lin JS, Kao ST, Ho FM (2010) Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutr Res 30(12):858–864. https://doi.org/10.1016/j.nutres.2010.10.011
Chaurasia S, Patel RR, Vure P, Mishra B (2018) Potential of cationic-polymeric nanoparticles for oral delivery of naringenin: in vitro and in vivo investigations. J Pharm Sci 107(2):706–716. https://doi.org/10.1016/j.xphs.2017.10.006
Combarros O, Sanchez-Juan P, Riancho JA, Mateo I, Rodriguez-Rodriguez E, Infante J, Garcia-Gorostiaga I, Vazquez-Higuera JL, Berciano J (2008) Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer’s disease risk. J Neural Transm (Vienna) 115(6):863–867. https://doi.org/10.1007/s00702-008-0028-5
Constantinescu CS, Farooqi N, O’Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079–1106. https://doi.org/10.1111/j.1476-5381.2011.01302.x
Delibas B, Kuruoglu E, Bereket MC, Onger ME (2021) Allantoin, a purine metabolite, enhances peripheral nerve regeneration following sciatic nerve injury in rats: a stereological and immunohistochemical study. J Chem Neuroanat 117:102002. https://doi.org/10.1016/j.jchemneu.2021.102002
Diel P, Thomae RB, Caldarelli A, Zierau O, Kolba S, Schmidt S, Schwab P, Metz P, Vollmer G (2004) Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats. Planta Med 70(1):39–44. https://doi.org/10.1055/s-2004-815453
Felgines C, Texier O, Morand C, Manach C, Scalbert A, Regerat F, Remesy C (2000) Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol 279(6):G1148-1154. https://doi.org/10.1152/ajpgi.2000.279.6.G1148
Fil’henkov OO, Zavelevych MP (2009) Comparative effects of flavonoids on cell cycle passage and apoptosis induction in human acute lymphoblastic leukemia MT-4 cells. Ukr Biokhim Zh 81(5):33–39
Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A (2007) Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179(5):3268–3275. https://doi.org/10.4049/jimmunol.179.5.3268
Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368(6468):237–239. https://doi.org/10.1038/368237a0
Fraga-Silva TF, Mimura LA, Zorzella-Pezavento SF, Ishikawa LL, Franca TG, Thome R, Verinaud L, Arruda MS, Sartori A (2016) Tolerogenic vaccination with MOG/VitD overcomes aggravating effect of C. albicans in experimental encephalomyelitis. CNS Neurosci Ther 22(10):807–816. https://doi.org/10.1111/cns.12572
Garay L, Gonzalez Giqueaux P, Guennoun R, Schumacher M, Gonzalez Deniselle MC, De Nicola AF (2017) Progesterone treatment modulates mRNA OF neurosteroidogenic enzymes in a murine model of multiple sclerosis. J Steroid Biochem Mol Biol 165(Pt B):421–429. https://doi.org/10.1016/j.jsbmb.2016.09.001
Garcia-Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL (2002) Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 450(3):256–271. https://doi.org/10.1002/cne.10325
Garcia-Segura LM, Melcangi RC (2006) Steroids and glial cell function. Glia 54(6):485–498. https://doi.org/10.1002/glia.20404
Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE, Hutchison JB (1999) Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 89(2):567–578. https://doi.org/10.1016/s0306-4522(98)00340-6
Ghofrani S, Joghataei MT, Mohseni S, Baluchnejadmojarad T, Bagheri M, Khamse S, Roghani M (2015) Naringenin improves learning and memory in an Alzheimer’s disease rat model: Insights into the underlying mechanisms. Eur J Pharmacol 764:195–201. https://doi.org/10.1016/j.ejphar.2015.07.001
Gold R, Hartung HP, Toyka KV (2000) Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 6(2):88–91. https://doi.org/10.1016/s1357-4310(99)01639-1
Griffith JS, Jensen SM, Lunceford JK, Kahn MW, Zheng Y, Falase EA, Lyttle CR, Teuscher C (1997) Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes. Am J Pathol 150(6):2223–2230
Guennoun R, Schumacher M, Robert F, Delespierre B, Gouezou M, Eychenne B, Akwa Y, Robel P, Baulieu EE (1997) Neurosteroids: expression of functional 3beta-hydroxysteroid dehydrogenase by rat sensory neurons and Schwann cells. Eur J Neurosci 9(11):2236–2247. https://doi.org/10.1111/j.1460-9568.1997.tb01642.x
Guennoun R, Meffre D, Labombarda F, Gonzalez SL, Gonzalez Deniselle MC, Stein DG, De Nicola AF, Schumacher M (2008) The membrane-associated progesterone-binding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. Brain Res Rev 57(2):493–505. https://doi.org/10.1016/j.brainresrev.2007.05.009
Guo D, Wang J, Wang X, Luo H, Zhang H, Cao D, Chen L, Huang N (2011) Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu). J Ethnopharmacol 138(2):451–457. https://doi.org/10.1016/j.jep.2011.09.034
Heim KE, Tagliaferro AR, Bobilya DJ (2002) Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13(10):572–584. https://doi.org/10.1016/s0955-2863(02)00208-5
Hofstetter HH, Shive CL, Forsthuber TG (2002) Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund’s adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J Immunol 169(1):117–125. https://doi.org/10.4049/jimmunol.169.1.117
Hovland AR, Powell RL, Takimoto GS, Tung L, Horwitz KB (1998) An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 273(10):5455–5460. https://doi.org/10.1074/jbc.273.10.5455
Jansson L, Mattsson A, Mattsson R, Holmdahl R (1990) Estrogen induced suppression of collagen arthritis. V: physiological level of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T-cell dependent immunity and stimulates polyclonal B-cell activity. J Autoimmun 3(3):257–270. https://doi.org/10.1016/0896-8411(90)90145-i
Jefferson WN, Padilla-Banks E, Clark G, Newbold RR (2002) Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J Chromatogr B Analyt Technol Biomed Life Sci 777(1–2):179–189. https://doi.org/10.1016/s1570-0232(02)00493-2
Jung-Testas I, Renoir M, Bugnard H, Greene GL, Baulieu EE (1992) Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Mol Biol 41(3–8):621–631. https://doi.org/10.1016/0960-0760(92)90394-x
Karayiğit MÖ, Yarim M (2018) Estrogen and progesterone synthesis with cellular response in a C57BL/6 mouse model of Cuprizone-induced demyelination. Acta Sci Vet 46(1):8
Kim S, Park TI (2013) Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells. Int J Clin Exp Med 6(10):890–899
Kim JH, Kang JW, Kim MS, Bak Y, Park YS, Jung KY, Lim YH, Yoon DY (2012) The apoptotic effects of the flavonoid N101–2 in human cervical cancer cells. Toxicol in Vitro 26(1):67–73. https://doi.org/10.1016/j.tiv.2011.10.012
Kimoto T, Asou H, Ohta Y, Mukai H, Chernogolov AA, Kawato S (1997) Digital fluorescence imaging of elementary steps of neurosteroid synthesis in rat brain glial cells. J Pharm Biomed Anal 15(9–10):1231–1240. https://doi.org/10.1016/s0731-7085(96)01987-5
Kinoshita Y, Chen S (2003) Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Res 63(13):3546–3555
Langub MC Jr, Watson RE Jr (1992) Estrogen receptor-immunoreactive glia, endothelia, and ependyma in guinea pig preoptic area and median eminence: electron microscopy. Endocrinology 130(1):364–372. https://doi.org/10.1210/endo.130.1.1727710
Lephart ED (1996) A review of brain aromatase cytochrome P450. Brain Res Brain Res Rev 22(1):1–26
Levine S, Sowinski R (1973) Experimental allergic encephalomyelitis in inbred and outbred mice. J Immunol 110(1):139–143
Lin SP, Hou YC, Tsai SY, Wang MJ, Chao PD (2014) Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats. Biomedicine (Taipei) 4:16. https://doi.org/10.7603/s40681-014-0016-z
Lozano-Herrera SJ, Luna-Barcenas G, Guevara-Gonzalez RG, Campos-Vega R, Solis-Sainz JC, Hernandez-Puga AG, Vergara-Castaneda HA (2022) Fermentation extract of naringenin increases the expression of estrogenic receptor beta and modulates genes related to the p53 signalling pathway, miR-200c and miR-141 in human colon cancer cells exposed to BPA. Molecules 27(19):1. https://doi.org/10.3390/molecules27196588
Mellon SH, Vaudry H (2001) Biosynthesis of neurosteroids and regulation of their synthesis. Neurosteroids Brain Funct 46:33–78
Miller SD, Karpus WJ, Davidson TS (2010) Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol 15:15 11 11-15 11 20. https://doi.org/10.1002/0471142735.im1501s88
Naftolin F (1994) Brain aromatization of androgens. J Reprod Med 39(4):257–261
Nicol T, Bilbey DL, Charles LM, Cordingley JL, Vernon-Roberts B (1964) Oestrogen: the natural stimulant of body defence. J Endocrinol 30:277–291. https://doi.org/10.1677/joe.0.0300277
Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Bruck W, Bishop D, Misgeld T, Kerschensteiner M (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17(4):495–499. https://doi.org/10.1038/nm.2324
Nilsson N, Carlsten H (1994) Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell Immunol 158(1):131–139. https://doi.org/10.1006/cimm.1994.1262
Niu X, Sang H, Wang J (2021) Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration. J Nutr Biochem 89:108560. https://doi.org/10.1016/j.jnutbio.2020.108560
O’Brien EE, Smeester BA, Michlitsch KS, Lee JH, Beitz AJ (2015) Colocalization of aromatase in spinal cord astrocytes: differences in expression and relationship to mechanical and thermal hyperalgesia in murine models of a painful and a non-painful bone tumor. Neuroscience 301:235–245. https://doi.org/10.1016/j.neuroscience.2015.06.009
Papalou O, Victor VM, Diamanti-Kandarakis E (2016) Oxidative stress in polycystic ovary syndrome. Curr Pharm Des 22(18):2709–2722. https://doi.org/10.2174/1381612822666160216151852
Pasanen S, Ylikomi T, Palojoki E, Syvala H, Pelto-Huikko M, Tuohimaa P (1998) Progesterone receptor in chicken bursa of Fabricius and thymus: evidence for expression in B-lymphocytes. Mol Cell Endocrinol 141(1–2):119–128. https://doi.org/10.1016/s0303-7207(98)00086-0
Pena CJ, Champagne FA (2015) Neonatal overexpression of estrogen receptor-alpha alters midbrain dopamine neuron development and reverses the effects of low maternal care in female offspring. Dev Neurobiol 75(10):1114–1124. https://doi.org/10.1002/dneu.22206
Polanczyk M, Zamora A, Subramanian S, Matejuk A, Hess DL, Blankenhorn EP, Teuscher C, Vandenbark AA, Offner H (2003) The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am J Pathol 163(4):1599–1605. https://doi.org/10.1016/s0002-9440(10)63516-x
Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J (2006) Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem 281(42):31950–31962. https://doi.org/10.1074/jbc.M603717200
Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F, Liang W (2011) Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell 2(6):507–516. https://doi.org/10.1007/s13238-011-1056-8
Sadasivam M, Ramatchandirin B, Balakrishnan S, Selvaraj K, Prahalathan C (2014) The role of phosphoenolpyruvate carboxykinase in neuronal steroidogenesis under acute inflammation. Gene 552(2):249–254. https://doi.org/10.1016/j.gene.2014.09.043
Santagati S, Melcangi RC, Celotti F, Martini L, Maggi A (1994) Estrogen receptor is expressed in different types of glial cells in culture. J Neurochem 63(6):2058–2064. https://doi.org/10.1046/j.1471-4159.1994.63062058.x
Simard J, Ricketts ML, Gingras S, Soucy P, Feltus FA, Melner MH (2005) Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev 26(4):525–582. https://doi.org/10.1210/er.2002-0050
Soma KK, Sinchak K, Lakhter A, Schlinger BA, Micevych PE (2005) Neurosteroids and female reproduction: estrogen increases 3beta-HSD mRNA and activity in rat hypothalamus. Endocrinology 146(10):4386–4390. https://doi.org/10.1210/en.2005-0569
Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683–747. https://doi.org/10.1146/annurev.immunol.23.021704.115707
Szekeres-Bartho J, Reznikoff-Etievant MF, Varga P, Pichon MF, Varga Z, Chaouat G (1989) Lymphocytic progesterone receptors in normal and pathological human pregnancy. J Reprod Immunol 16(3):239–247. https://doi.org/10.1016/0165-0378(89)90053-3
Tiwari-Woodruff S, Voskuhl RR (2009) Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J Neurol Sci 286(1–2):81–85. https://doi.org/10.1016/j.jns.2009.04.023
Totta P, Acconcia F, Leone S, Cardillo I, Marino M (2004) Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. IUBMB Life 56(8):491–499. https://doi.org/10.1080/15216540400010792
Tran M, Kuhn JA, Braz JM, Basbaum AI (2017) Neuronal aromatase expression in pain processing regions of the medullary and spinal cord dorsal horn. J Comp Neurol 525(16):3414–3428. https://doi.org/10.1002/cne.24269
Uotinen N, Puustinen R, Pasanen S, Manninen T, Kivineva M, Syvala H, Tuohimaa P, Ylikomi T (1999) Distribution of progesterone receptor in female mouse tissues. Gen Comp Endocrinol 115(3):429–441. https://doi.org/10.1006/gcen.1999.7333
Van Vollenhoven RF, McGuire JL (1994) Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases? Cleve Clin J Med 61(4):276–284. https://doi.org/10.3949/ccjm.61.4.276
Wang J, Niu X, Wu C, Wu D (2018a) Naringenin modifies the development of lineage-specific effector CD4(+) T cells. Front Immunol 9:2267. https://doi.org/10.3389/fimmu.2018.02267
Wang J, Qi Y, Niu X, Tang H, Meydani SN, Wu D (2018b) Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice. J Nutr Biochem 54:130–139. https://doi.org/10.1016/j.jnutbio.2017.12.004
Xu Z, Huang B, Liu J, Wu X, Luo N, Wang X, Zheng X, Pan X (2018) Combinatorial anti-proliferative effects of tamoxifen and naringenin: the role of four estrogen receptor subtypes. Toxicology 410:231–246. https://doi.org/10.1016/j.tox.2018.08.013
Yarim GF, Yarim M, Sozmen M, Gokceoglu A, Ertekin A, Kabak YB, Karaca E (2022) Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model. Fitoterapia 156:105099. https://doi.org/10.1016/j.fitote.2021.105099
Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (2003) Interaction between flavonoids and the blood–brain barrier: in vitro studies. J Neurochem 85(1):180–192. https://doi.org/10.1046/j.1471-4159.2003.01652.x
Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R (2005) Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer’s disease animal model. Proc Natl Acad Sci USA 102(52):19198–19203. https://doi.org/10.1073/pnas.0505203102
Zhong YH, Dhawan J, Kovoor JA, Sullivan J, Zhang WX, Choi D, Biegon A (2017) Aromatase and neuroinflammation in rat focal brain ischemia. J Steroid Biochem Mol Biol 174:225–233. https://doi.org/10.1016/j.jsbmb.2017.09.019
Zierau O, Gester S, Schwab P, Metz P, Kolba S, Wulf M, Vollmer G (2002) Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med 68(5):449–451. https://doi.org/10.1055/s-2002-32089
Zierau O, Hamann J, Tischer S, Schwab P, Metz P, Vollmer G, Gutzeit HO, Scholz S (2005) Naringenin-type flavonoids show different estrogenic effects in mammalian and teleost test systems. Biochem Biophys Res Commun 326(4):909–916. https://doi.org/10.1016/j.bbrc.2004.11.124
Zwain IH, Yen SS, Cheng CY (1997) Astrocytes cultured in vitro produce estradiol-17beta and express aromatase cytochrome P-450 (P-450 AROM) mRNA. Biochim Biophys Acta 1334(2–3):338–348. https://doi.org/10.1016/s0304-4165(96)00115-8
Acknowledgements
This study was funded by Ondokuz Mayıs University under grant PYO.VET.1904.17.015.
Author information
Authors and Affiliations
Contributions
All authors were involved in all stages of the research submitted.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
We certify that this manuscript is original and has not previously been published. We have read and have abided by the statement of ethical standards for manuscripts submitted to “Histochemistry and Cell Biology” journal. And the study is not split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time. No data have been fabricated or manipulated (including images) to support our conclusions. No data, text, or theories by others are presented as if they were our own. We also confirm that all the listed authors have participated actively in the study, and have seen and approved the submitted manuscript. The authors do not have any possible conflicts of interest. This article does not contain any studies with human participants performed by any of the authors. The authors declare that all experimental protocols were approved by the Ethics Committee, Ondokuz Mayıs University Animal Experiments Local Ethics Committee Samsun, Turkey (no: 2016-11). All methods were carried out in accordance with relevant guidelines and regulations.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Karaca, E., Yarim, M. Naringenin stimulates aromatase expression and alleviates the clinical and histopathological findings of experimental autoimmune encephalomyelitis in C57bl6 mice. Histochem Cell Biol 160, 477–490 (2023). https://doi.org/10.1007/s00418-023-02217-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-023-02217-1